Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Inghirami

Showing results (101-110 of 239) with videos related to

Pageof 24
Sort By:
Cell Reports|January 23, 2020
Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast CancerShira Yomtoubian, Sharrell B Lee, Akanksha Verma, et al.
Oncotarget|October 30, 2016
Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypesMichela Boi, Maria Todaro, Valentina Vurchio, et al.
Blood|June 29, 2012
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphomaLuca Agnelli, Elisabetta Mereu, Elisa Pellegrino, et al.
Haematologica|August 27, 2013
STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphomaElisa Spaccarotella, Elisa Pellegrino, Manuela Ferracin, et al.
Leukemia & Lymphoma|May 24, 2011
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjectsLudovica Riera, Elena Lasorsa, Lisa Bonello, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 19, 2016
Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular MorphologyAlessia Nottegar, Fabrizio Tabbò, Claudio Luchini, et al.
Blood|August 18, 2005
p130Cas mediates the transforming properties of the anaplastic lymphoma kinaseChiara Ambrogio, Claudia Voena, Andrea D Manazza, et al.
Blood|August 8, 2018
PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survivalXiaoqing Lu, Tharu M Fernando, Chen Lossos, et al.
Blood|April 27, 2011
The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathwayPaola Martinelli, Paola Bonetti, Cristina Sironi, et al.
Leukemia & Lymphoma|May 4, 2019
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemiaIrene Della Starza, Lucia Anna De Novi, Alessandra Santoro, et al.
Pageof 24

Showing results (101-110 of 239) with videos related to

Sort By:
Pageof 24
Cell Reports|January 23, 2020
Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast CancerShira Yomtoubian, Sharrell B Lee, Akanksha Verma, et al.
Oncotarget|October 30, 2016
Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypesMichela Boi, Maria Todaro, Valentina Vurchio, et al.
Blood|June 29, 2012
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphomaLuca Agnelli, Elisabetta Mereu, Elisa Pellegrino, et al.
Haematologica|August 27, 2013
STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphomaElisa Spaccarotella, Elisa Pellegrino, Manuela Ferracin, et al.
Leukemia & Lymphoma|May 24, 2011
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjectsLudovica Riera, Elena Lasorsa, Lisa Bonello, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 19, 2016
Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular MorphologyAlessia Nottegar, Fabrizio Tabbò, Claudio Luchini, et al.
Blood|August 18, 2005
p130Cas mediates the transforming properties of the anaplastic lymphoma kinaseChiara Ambrogio, Claudia Voena, Andrea D Manazza, et al.
Blood|August 8, 2018
PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survivalXiaoqing Lu, Tharu M Fernando, Chen Lossos, et al.
Blood|April 27, 2011
The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathwayPaola Martinelli, Paola Bonetti, Cristina Sironi, et al.
Leukemia & Lymphoma|May 4, 2019
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemiaIrene Della Starza, Lucia Anna De Novi, Alessandra Santoro, et al.
Pageof 24